Gemifloxacin mesylate is a novel fourth generation fluoroquinolone agent that is used for the treatment of community acquired pneumonia and acute bacterial exacerbation of chronic bronchitis that provide high rates of mortality worldwide. Это и многое другое вы найдете в книге Spectrofluorometric Methods for Determination of Gemifloxacin Mesylate (Wesam El-Koussi,Noha Atia and Ashraf Mahmoud)